Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000726335 | SCV000343846 | uncertain significance | not provided | 2016-09-04 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000297549 | SCV000530215 | likely benign | not specified | 2016-08-03 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV001088758 | SCV001008745 | likely benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002348021 | SCV002645949 | likely benign | Cardiovascular phenotype | 2020-07-13 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000726335 | SCV004150274 | likely benign | not provided | 2022-07-01 | criteria provided, single submitter | clinical testing | TTN: BP4, BP7 |
CHEO Genetics Diagnostic Laboratory, |
RCV003486808 | SCV004240118 | likely benign | Cardiomyopathy | 2023-05-16 | criteria provided, single submitter | clinical testing |